Brief: Nextcell Pharma Q3 Oper Loss Widens To SEK 10.9 Mln
27/07/2023 06:36
July 27 (Reuters) - NextCell Pharma AB NXTCL.ST :
* Q3 OPERATING INCOME SEK 4.2 MILLION VERSUS SEK 1.6 MILLION
YEAR
AGO
* Q3 OPERATING LOSS SEK 10.9 MILLION VERSUS LOSS SEK 9.3
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr1ZVTdH
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln